Emily Field
Stock Analyst at Barclays
(3.01)
# 2,718
Out of 4,651 analysts
843
Total ratings
45.8%
Success rate
1.9%
Average return
Main Sectors:
Stocks Rated by Emily Field
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Buy | $1,400 | $1,220.28 | +14.73% | 26 | Aug 17, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $95 → $110 | $75.64 | +45.43% | 8 | Aug 14, 2026 | |
| PFE Pfizer | Maintained: Sell | $25 | $26.31 | -4.98% | 6 | Aug 14, 2026 | |
| MRK Merck & Co. | Maintained: Buy | $150 | $132.92 | +12.85% | 12 | Aug 14, 2026 | |
| GILD Gilead Sciences | Maintained: Hold | $145 | $135.87 | +6.72% | 5 | Aug 14, 2026 | |
| AMGN Amgen | Maintained: Hold | $360 → $380 | $416.18 | -8.69% | 8 | Aug 14, 2026 | |
| BIIB Biogen | Maintained: Hold | $200 | $208.87 | -4.25% | 7 | Aug 12, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Buy | $75 | $63.70 | +17.74% | 7 | Jul 31, 2026 | |
| ABBV AbbVie | Maintained: Buy | $275 → $300 | $248.76 | +20.60% | 10 | Jul 29, 2026 | |
| GSK GSK plc | Downgraded: Sell | n/a | $50.30 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $152.32 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $43.71 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $56.51 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 275.00 | CHF 363.60 | -24.37% | 59 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 1,450p | 1,850p | n/a | 126 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €115.00 → €105.00 | €75.19 | n/a | 37 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 46.50 → CHF 55.00 | CHF 72.84 | n/a | 9 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 700.00 → kr 375.00 | kr 299.50 | n/a | 54 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 14,000p | 11,626p | n/a | 78 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €22.00 | €24.38 | n/a | 32 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | CHF 90.00 | CHF 123.78 | n/a | 44 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €25.00 | €48.15 | n/a | 59 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 2,000p | 1,630p | n/a | 61 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 2,100 | kr 2,024 | n/a | 45 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €195.00 | €138.95 | n/a | 74 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €390.00 → €430.00 | €759.00 | n/a | 21 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €8.00 → €9.00 | €10.10 | n/a | 4 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €75.00 | €154.10 | n/a | 22 | Nov 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €125.00 → €90.00 | €222.53 | n/a | 14 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $144 → $125 | $27.93 | n/a | 7 | Jan 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $52.82 | $19.32 | n/a | 1 | Aug 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $0.00001 | n/a | 1 | Apr 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $7.93 | n/a | 2 | Jun 1, 2018 |
Eli Lilly and Company
Aug 17, 2026
Maintained: Buy
Price Target: $1,400
Current: $1,220.28
Upside: +14.73%
Cytokinetics
Aug 14, 2026
Maintained: Buy
Price Target: $95 → $110
Current: $75.64
Upside: +45.43%
Pfizer
Aug 14, 2026
Maintained: Sell
Price Target: $25
Current: $26.31
Upside: -4.98%
Merck & Co.
Aug 14, 2026
Maintained: Buy
Price Target: $150
Current: $132.92
Upside: +12.85%
Gilead Sciences
Aug 14, 2026
Maintained: Hold
Price Target: $145
Current: $135.87
Upside: +6.72%
Amgen
Aug 14, 2026
Maintained: Hold
Price Target: $360 → $380
Current: $416.18
Upside: -8.69%
Biogen
Aug 12, 2026
Maintained: Hold
Price Target: $200
Current: $208.87
Upside: -4.25%
Bristol-Myers Squibb Company
Jul 31, 2026
Maintained: Buy
Price Target: $75
Current: $63.70
Upside: +17.74%
AbbVie
Jul 29, 2026
Maintained: Buy
Price Target: $275 → $300
Current: $248.76
Upside: +20.60%
GSK plc
Jan 6, 2026
Downgraded: Sell
Price Target: n/a
Current: $50.30
Upside: -
Jan 6, 2026
Upgraded: Hold
Price Target: n/a
Current: $152.32
Upside: -
Jan 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $43.71
Upside: -
Jan 6, 2026
Upgraded: Buy
Price Target: n/a
Current: $56.51
Upside: -
Sep 24, 2025
Maintained: Hold
Price Target: CHF 275.00
Current: CHF 363.60
Upside: -24.37%
Aug 12, 2025
Maintained: Hold
Price Target: 1,450p
Current: 1,850p
Upside: n/a
Aug 12, 2025
Maintained: Buy
Price Target: €115.00 → €105.00
Current: €75.19
Upside: n/a
Aug 8, 2025
Maintained: Buy
Price Target: CHF 46.50 → CHF 55.00
Current: CHF 72.84
Upside: n/a
Aug 4, 2025
Maintained: Hold
Price Target: kr 700.00 → kr 375.00
Current: kr 299.50
Upside: n/a
Jul 30, 2025
Maintained: Buy
Price Target: 14,000p
Current: 11,626p
Upside: n/a
Jul 29, 2025
Maintained: Sell
Price Target: €22.00
Current: €24.38
Upside: n/a
Jul 21, 2025
Maintained: Sell
Price Target: CHF 90.00
Current: CHF 123.78
Upside: n/a
Jun 27, 2025
Maintained: Hold
Price Target: €25.00
Current: €48.15
Upside: n/a
Apr 25, 2025
Maintained: Hold
Price Target: 2,000p
Current: 1,630p
Upside: n/a
Apr 15, 2025
Maintained: Buy
Price Target: kr 2,100
Current: kr 2,024
Upside: n/a
Oct 29, 2024
Maintained: Buy
Price Target: €195.00
Current: €138.95
Upside: n/a
Jun 21, 2023
Maintained: Buy
Price Target: €390.00 → €430.00
Current: €759.00
Upside: n/a
Nov 21, 2022
Maintained: Sell
Price Target: €8.00 → €9.00
Current: €10.10
Upside: n/a
Nov 25, 2021
Maintained: Sell
Price Target: €75.00
Current: €154.10
Upside: n/a
Oct 15, 2021
Downgraded: Hold
Price Target: €125.00 → €90.00
Current: €222.53
Upside: n/a
Jan 19, 2021
Maintained: Hold
Price Target: $144 → $125
Current: $27.93
Upside: n/a
Aug 28, 2020
Maintained: Hold
Price Target: $52.82
Current: $19.32
Upside: n/a
Apr 25, 2019
Maintained: Buy
Price Target: $14
Current: $0.00001
Upside: n/a
Jun 1, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $7.93
Upside: n/a